Well Health Tech Stock Price, News & Analysis

WELL Health Technologies (WHTCF) has appointed Ric Leong as Chief Accounting Officer, effective May 20th. Leong, who holds CPA, CA credentials and a BSc degree, will lead WELL's accounting operations and financial planning functions. He brings significant experience from his previous roles as CFO of Avigilon during its $1B acquisition by Motorola Solutions, and most recently as SVP of Finance at Hootsuite. In his new role, Leong will focus on strengthening financial reporting processes, supporting WELL's acquisition strategy through financial integration, and enhancing financial planning and analysis capabilities. He will report to CFO Eva Fong and work closely with WELL's leadership team to support the company's growth objectives in the digital healthcare sector.

WELL Health Technologies (WHTCF) announces that three of its subsidiaries - Intrahealth, Pentavere, and OceanMD - have been selected for Canada Health Infoway's 2025 Vendor Innovation Program. These subsidiaries, representing three out of eight total winners, will develop projects focused on improving healthcare interoperability across Canada. Pentavere will integrate its DARWEN™ AI system with EMRs, OceanMD will enhance its eReferral system with AI automation, and Intrahealth will develop FHIR-based tools for patient record transfers. The projects will be implemented across multiple provinces including Alberta, British Columbia, Ontario, New Brunswick, and Nova Scotia, aiming to improve data quality, enhance care coordination, and expand access to standardized health information.

WELL Health Technologies (WHTCF) has established an automatic share purchase plan (ASPP) to facilitate its previously announced normal course issuer bid (NCIB). The company received TSX approval to repurchase up to 6,326,417 common shares, representing approximately 2.5% of its 253,056,708 outstanding shares, between May 20, 2025, and May 19, 2026.

The ASPP allows WELL's broker to purchase shares during periods when the company would typically be restricted from trading due to insider trading rules and internal blackout periods. Purchases will be made based on pre-set parameters established by WELL when it has no undisclosed material information.

["Company authorized to repurchase 6.3M shares (2.5% of outstanding shares)", "ASPP enables consistent share repurchases even during blackout periods", "Share buyback demonstrates management's confidence in company value"]

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has received approval from the Toronto Stock Exchange for its renewed Normal Course Issuer Bid (NCIB). The program allows WELL to repurchase up to 6,326,417 shares, representing 2.5% of its outstanding shares, over a 12-month period from May 20, 2025 to May 19, 2026.

Daily purchases on the TSX will be limited to 284,830 shares. Under the previous 2024 NCIB, WELL purchased 298,500 shares at an average price of $4.91. The company's limited buyback activity was due to their previous broker Eight Capital winding down operations and funds being allocated to alternative opportunities.

WELL Health Technologies (WHTCF) reported record Q1-2025 revenue of $294.1M, up 32% YoY. The company achieved Adjusted EBITDA of $27.6M, a 36% increase YoY. Total patient visits reached 1.6M, up 23% YoY, with Canadian visits growing 29%. Canadian operations showed strong 13% organic growth. Revenue was impacted by a $6.5M delay in Circle Medical revenue recognition. The company's Canadian business, including WELLSTAR and CYBERWELL, grew Four wall Adjusted EBITDA by 29% YoY to $18.7M. Looking ahead, WELL expects to integrate HEALWELL AI in Q2 2025, contributing approximately $120M in 2025 revenue. The company plans to reinitiate its share buyback program and has 11 signed LOIs worth $65M in revenues in its M&A pipeline.

WELL Health Technologies (WHTCF) reported strong Q1 2025 operational results, achieving record 1.6 million patient visits, representing 24% YoY growth with 14% organic growth. The company's Canadian operations led growth with 933,493 patient visits, showing 30% YoY growth (12% organic). Total care interactions reached 2.59 million, up 34% YoY. Technology interactions increased by 53% to 856,659, while billed provider hours grew 53% to 132,146. However, the company noted a $6.5M revenue impact due to Circle Medical's deferred revenue recognition, with approximately $58.4M in deferred revenue on the balance sheet. WELL will release its complete Q1 2025 financial results on May 14, 2025.

WELLSTAR Technologies, a subsidiary of WELL Health Technologies (TSX:WELL, OTCQX:WHTCF), has launched Nexus AI, a Canadian-built artificial intelligence platform for healthcare providers. The platform features advanced ambient scribe capabilities and integrates with Canadian EMR systems to streamline clinical workflows and reduce administrative burden.

Developed by physicians and AI researchers from the University of Toronto and HEALWELL AI, Nexus AI is already being used by thousands of providers across 20 specialties in Canada. The platform will expand to include disease detection, medical coding, billing automation, and clinical decision support features. Notably, Nexus AI is participating in Canada Health Infoway's AI Scribe Program, which will fund one-year licenses for up to 10,000 eligible primary care clinicians.

WELL Health Technologies (TSX: WELL) has rebranded its cybersecurity division as 'CYBERWELL', consolidating four trusted cybersecurity businesses - Source44, SeekIntoo, Cycura, and Proack Security - into a unified data protection platform. The company has appointed Jeffrey Engle, a seasoned cybersecurity executive and U.S. special operations veteran, as CEO to lead the division. Under Engle's leadership, CYBERWELL will focus on driving growth through recurring revenue, disciplined acquisitions, and international expansion, particularly targeting healthcare and critical infrastructure sectors. The strategic consolidation aims to enhance operational efficiency, strengthen brand equity, and position WELL to better serve the growing demand for advanced cybersecurity capabilities across North America and beyond. WELL indicates that CYBERWELL may be considered for a future spinout, potentially creating additional shareholder value.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has scheduled the release of its Fourth Quarter and Year End 2024 financial results on April 14, 2025, after market close. The digital healthcare company will host a conference call and webcast to discuss the results on April 15, 2025, at 1:00 PM ET (10:00 AM PT).

The earnings call will be led by Chairman and CEO Hamed Shahbazi and CFO Eva Fong. Participants can join through various dial-in options, including local Toronto (437-900-0527), Vancouver (604-259-0841), North American toll-free (1-888-510-2154), and international lines.